![Shane Schaffer](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Fortuna: 73 678 $ al 31/08/2026
Shane J.
Schaffer was the founder of Cingulate, Inc., founded in 2012, serving as Chairman & Chief Executive Officer from 2012 to 2025.
Dr. Schaffer is the founder of Cingulate Works, Inc., founded in 2013, serving as Chairman & Chief Executive Officer since 2013.
Dr. Schaffer was the founder of Cingulate, Inc., founded in 2025, serving as Chairman & Chief Executive Officer since 2026.
Dr. Schaffer is also the founder of Cingulate Therapeutics LLC..
Dr. Schaffer was Director-National Accounts at DBC Pri-Med LLC from 2008 to 2009.
Dr. Schaffer was Managing Director at Sabre Scientific Solutions from 2009 to 2012.
Dr. Schaffer was Marketing Manager at Novartis International AG from 2001 to 2003.
Dr. Schaffer was Clinical Research Associate at Hoechst Marion Roussel, Inc. from 1997 to 1999.
Dr. Schaffer was Senior Manager-Marketing at Sanofi from 2004 to 2007.
Dr. Schaffer earned a doctorate from KU School of Pharmacy.
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
CINGULATE, INC. 0,1 % | 16/07/2026 | 14.251 ( 0,1 % ) | 73 678 $ | 31/08/2026 |
| Empresas | Cargo | Inicio |
|---|---|---|
| CINGULATE INC. | Director Ejecutivo | 15/12/2025 |
Cingulate Therapeutics LLC
 Cingulate Therapeutics LLC Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that focuses on develops attention deficit/hyperactivity disorder products | Director Ejecutivo | 01/01/2013 |
Cingulate Works, Inc.
 Cingulate Works, Inc. Pharmaceuticals: MajorHealth Technology Develops biopharmaceuticals for the treatment of central nervous system and neurobiological disorders | Director Ejecutivo | 01/01/2013 |
| Empresas | Cargo | Fin |
|---|---|---|
| CINGULATE INC. | Director Ejecutivo | 14/08/2025 |
Sabre Scientific Solutions | Corporate Officer/Principal | 01/12/2012 |
DBC Pri-Med LLC
 DBC Pri-Med LLC Miscellaneous Commercial ServicesCommercial Services Provides live medical educational conferences and other educational platform for science and medicine | Corporate Officer/Principal | 01/05/2009 |
| SANOFI | Ventas & Marketing | 01/12/2007 |
Novartis International AG
 Novartis International AG Pharmaceuticals: MajorHealth Technology Offers healthcare solutions | Ventas & Marketing | 01/10/2003 |
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
| Empresas privadas | 9 |
|---|---|
Novartis International AG
Novartis International AG Pharmaceuticals: MajorHealth Technology Offers healthcare solutions | Health Technology |
Sanofi
 Sanofi Pharmaceuticals: MajorHealth Technology Engages in research, development and production of pharmaceuticals & vaccines | Health Technology |
Cingulate Therapeutics LLC
Cingulate Therapeutics LLC Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that focuses on develops attention deficit/hyperactivity disorder products | Health Technology |
Hoechst Marion Roussel, Inc.
 Hoechst Marion Roussel, Inc. Pharmaceuticals: GenericHealth Technology Develops, manufactures and sells generic pharmaceutical products | Health Technology |
DBC Pri-Med LLC
DBC Pri-Med LLC Miscellaneous Commercial ServicesCommercial Services Provides live medical educational conferences and other educational platform for science and medicine | Commercial Services |
KU School of Pharmacy
 KU School of Pharmacy Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Cingulate Works, Inc.
Cingulate Works, Inc. Pharmaceuticals: MajorHealth Technology Develops biopharmaceuticals for the treatment of central nervous system and neurobiological disorders | Health Technology |
Cingulate, Inc.
 Cingulate, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceuticals | Health Technology |
Sabre Scientific Solutions |
Selecciona tu edición
Toda la información financiera adaptada al ámbito nacional.
